PA
HLF icon

PharVision Advisers’s Herbalife HLF Stock Holding History

PharVision Advisers’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176K Sell
11,930
-37,985
-76% -$621K 1.78% 4
2025
Q4 		$643K Sell
49,915
-7,405
-13% -$78.4K 0.33% 8
2025
Q3 		$484K Buy
+57,320
New +$541K 0.27% 27
2025
Q1 		– Sell
-107,691
Closed -$720K – 382
2024
Q4 		$720K Buy
+107,691
New +$800K 0.61% 14

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's HLF Position: Q1 2026 in Review

PharVision Advisers reduced its Herbalife (HLF) stake by 76% in Q1 2026, selling an estimated $621K and leaving 11,930 shares worth $176K. The position accounts for 1.78% of the portfolio, ranked #4.

PharVision Advisers first reported a position in HLF in Q4 2024 and has held it in 4 quarters since. The position peaked at $720K in Q4 2024. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • PharVision Advisers held 11,930 shares of Herbalife worth $176K as of Q1 2026.
  • PharVision Advisers sold 37,985 Herbalife shares in Q1 2026, an estimated $621K.
  • Herbalife made up 1.78% of PharVision Advisers's portfolio in Q1 2026, its #4 holding.
  • PharVision Advisers first reported a position in Herbalife in Q4 2024 and has held it in 4 quarters since.
  • PharVision Advisers's Herbalife position peaked at $720K in Q4 2024.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.